Country-Specific vs. Common Birthweight-for-Gestational Age References to Identify Small for Gestational Age Infants Born at 24-28 weeks: An International Study by Martin, Lisa J et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Country-Specific vs. Common Birthweight-for-Gestational Age References
to Identify Small for Gestational Age Infants Born at 24-28 weeks: An
International Study
Martin, Lisa J; Sjörs, Gunnar; Reichman, Brian; Darlow, Brian A; Morisaki, Naho; Modi, Neena;
Bassler, Dirk; Mirea, Lucia; Adams, Mark; Kusuda, Satoshi; Lui, Kei; Feliciano, Laura San; Håkansson,
Stellan; Isayama, Tetsuya; Mori, Rintaro; Vento, Max; Lee, Shoo K; Shah, Prakesh S
Abstract: BACKGROUND Controversy exists as to whether birthweight-for-gestational age references
used to classify infants as small for gestational age (SGA) should be country specific or based on an
international (common) standard. We examined whether different birthweight-for-gestational age refer-
ences affected the association of SGA with adverse outcomes among very preterm neonates. METHODS
Singleton infants (n = 23 788) of 24(0) -28(6) weeks’ gestational age in nine high-resource countries were
classified as SGA (<10th centile) using common and country-specific references based on birthweight and
estimated fetal weight (EFW). For each reference, the adjusted relative risk (aRR) for the association of
SGA with composite outcome of mortality or major morbidity was estimated. RESULTS The percentage
of infants classified as SGA differed slightly for common compared with country specific for birthweight
references [9.9% (95% CI 9.5, 10.2) vs. 11.1% (95% CI 10.7, 11.5)] and for EFW references [28.6% (95%
CI 28.0, 29.2) vs. 24.6% (95% CI 24.1, 25.2)]. The association of SGA with the composite outcome was
similar when using common or country-specific references for the total sample for birthweight [aRRs 1.47
(95% CI 1.43, 1.51) and 1.48 (95% CI 1.44, 1.53) respectively] and for EFW references [aRRs 1.35 (95%
CI 1.31, 1.38) and 1.39 (95% CI 1.35, 1.43) respectively]. CONCLUSION Small for gestational age is
associated with higher mortality and morbidity in infants born <29 weeks’ gestational age. Although
common and country-specific birthweight/EFW references identified slightly different proportions of SGA
infants, the risk of the composite outcome was comparable.
DOI: https://doi.org/10.1111/ppe.12298
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-124547
Accepted Version
Originally published at:
Martin, Lisa J; Sjörs, Gunnar; Reichman, Brian; Darlow, Brian A; Morisaki, Naho; Modi, Neena; Bassler,
Dirk; Mirea, Lucia; Adams, Mark; Kusuda, Satoshi; Lui, Kei; Feliciano, Laura San; Håkansson, Stellan;
Isayama, Tetsuya; Mori, Rintaro; Vento, Max; Lee, Shoo K; Shah, Prakesh S (2016). Country-Specific
vs. Common Birthweight-for-Gestational Age References to Identify Small for Gestational Age Infants
Born at 24-28 weeks: An International Study. Paediatric and Perinatal Epidemiology:online.
DOI: https://doi.org/10.1111/ppe.12298
Country-Speciﬁc vs. Common Birthweight-for-Gestational Age
References to Identify Small for Gestational Age Infants Born at
24–28 weeks: An International Study
Lisa J. Martin,a Gunnar Sj€ors,b Brian Reichman,c Brian A. Darlow,d Naho Morisaki,e Neena Modi,f Dirk Bassler,g Lucia Mirea,a Mark
Adams,g Satoshi Kusuda,h Kei Lui,i Laura San Feliciano,j Stellan Hakansson,k Tetsuya Isayama,a Rintaro Mori,l Max Vento,m Shoo
K. Lee,a Prakesh S. Shah,a on behalf of the International Network for Evaluating Outcomes (iNeo) of Neonates Investigators
aMaternal-Infant Care Research Centre, Mount Sinai Hospital, Canadian Neonatal Network,Toronto, ON, Canada
bSwedish Neonatal Quality Register, Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
cGertner Institute for Epidemiology and Health Policy Research, Sheba Medical Centre, Israel Neonatal Network, Tel Hashomer, Israel
dAustralia and New Zealand Neonatal Network, Department of Paediatrics, University of Otago, Christchurch, New Zealand
eDepartment of Social Medicine, National Center for Child Health and Development, Neonatal Research Network Japan, Setagaya-ku, Tokyo, Japan
fNeonatal Data Analysis Unit, Section of Neonatal Medicine, Department of Medicine, Imperial College London, UK Neonatal Collaborative,
London, UK
gSwiss Neonatal Network, Department of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
hNeonatal Research Network Japan, Maternal and Perinatal Center, Tokyo Women’s Medical University, Shinjuku, Tokyo, Japan
iAustralian and New Zealand Neonatal Network,Royal Hospital for Women,National Perinatal Epidemiology and Statistic Unit,University of New
South Wales, Randwick, NSW, Australia
jSpanish Neonatal Network, Hospital Universitario de Salamanca, Valencia, Spain
kSwedish Neonatal Quality Register, Department of Pediatrics/Neonatal Services, Umea University Hospital, Umea, Sweden
lNeonatal Research Network Japan, Department of Health Policy, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan
mSpanish Neonatal Network, Health Research Institute La Fe, Valencia, Spain
Abstract
Background: Controversy exists as to whether birthweight-for-gestational age references used to classify infants as
small for gestational age (SGA) should be country specific or based on an international (common) standard. We
examined whether different birthweight-for-gestational age references affected the association of SGA with
adverse outcomes among very preterm neonates.
Methods: Singleton infants (n = 23 788) of 240–286 weeks’ gestational age in nine high-resource countries were
classified as SGA (<10th centile) using common and country-specific references based on birthweight and
estimated fetal weight (EFW). For each reference, the adjusted relative risk (aRR) for the association of SGA with
composite outcome of mortality or major morbidity was estimated.
Results: The percentage of infants classified as SGA differed slightly for common compared with country specific
for birthweight references [9.9% (95% CI 9.5, 10.2) vs. 11.1% (95% CI 10.7, 11.5)] and for EFW references [28.6%
(95% CI 28.0, 29.2) vs. 24.6% (95% CI 24.1, 25.2)]. The association of SGA with the composite outcome was similar
when using common or country-specific references for the total sample for birthweight [aRRs 1.47 (95% CI 1.43, 1.51)
and 1.48 (95% CI 1.44, 1.53) respectively] and for EFW references [aRRs 1.35 (95% CI 1.31, 1.38) and 1.39 (95% CI
1.35, 1.43) respectively].
Conclusion: Small for gestational age is associated with higher mortality and morbidity in infants born <29 weeks’
gestational age. Although common and country-specific birthweight/EFW references identified slightly different
proportions of SGA infants, the risk of the composite outcome was comparable.
Keywords: Infant, Small for Gestational Age; Infant, Extremely Premature; Neonatal outcomes.
Fetal growth restriction is a risk factor for perinatal mor-
tality, morbidity, and adverse long-term outcomes.1–3
Newborns are classified as small for gestational age
(SGA) when birthweight is below the 10th centile of
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birthweight-for-gestational age. Neonates who are
SGA are at higher risk of neonatal complications,
such as hypoglycaemia, polycythaemia, acute and
chronic pulmonary changes, and nutritional and
metabolic alterations which can lead to long-term
neurodevelopmental and metabolic consequences
even at extremely low gestations. Identification of a
fetus as IUGR can lead to extra monitoring of fetus,
administration of antenatal steroid (far away from
actual birth with diminished efficacy), and/or inter-
vention to expedite birth. Similarly, management of
a SGA preterm neonate differs with extra monitor-
ing for sugar, blood counts, and investigations to
identify cause for SGA along with careful respira-
tory monitoring and management and altered
feeding pattern (slower than usual) and watch for
gastrointestinal consequences such as necrotising
enterocolitis. The percentage of infants classified as
SGA is also a potential case-mix confounding factor in
cohort studies evaluating variations in neonatal
outcomes across different populations.4 However, the
choice of birthweight-for-gestational age reference
influences the classification of infants as SGA and may
impact research findings and clinical practice.5,6
Controversy exists regarding the use of a common
(international) reference or population-specific birth-
weight-for-gestational age references to classify infants
as SGA.7–9 Variation in the observed birthweight-for-
gestational age exists between countries and different
ethnicities.7,10 If this variation reflects physiologic dif-
ferences in birthweight, then it may be appropriate to
use country-specific birthweight-for-gestational age
references. However, if optimal fetal growth and birth
size are similar across populations when maternal
health, social, and nutritional conditions are optimal,11
then a common birthweight-for-gestational age refer-
ence could appropriately be applied.
Another controversy exists regarding the use of
birthweight-for-gestational age references based on
birthweight or on ultrasound-derived estimates of
fetal weight (EFW). Descriptive references, such as the
Fenton chart,12 are derived from observed birth-
weights of infants born at various gestational ages
and may underdiagnose SGA,13 because infants born
preterm are more likely to be growth restricted than
their counterparts who remain in utero. In contrast,
EFW references use estimates of the expected weight
of a fetus at a specific gestational age, assuming it had
remained in utero until term delivery, and may avoid
the bias associated with descriptive birthweight-
for-gestational age references.14 However, EFW may
have substantial measurement error.15 There is no con-
sensus as to which type of birthweight-for-gestational
age reference is best to identify SGA infants.
The objectives of this study were (i) to estimate the
percentage of infants classified as SGA using common
and country-specific references based on both birth-
weight and EFW among very preterm infants in nine
countries, (ii) to evaluate the effect of classifying
infants as SGA by different birthweight-for-
gestational age references on the association of SGA
with a composite outcome (comprising neonatal mor-
tality or major morbidity), and (iii) to examine
whether adjusting for SGA derived from different
birthweight-for-gestational age references affects the
estimated risk of the composite outcome between
populations.
Methods
Population
Data on neonates were retrieved from the Interna-
tional Network for Evaluating Outcomes in Neonates
(iNeo) database, which contains individual-level data
on neonatal characteristics and outcomes from eight
national data collection systems (nine countries)
between 2007 and 2010.4 This included the Australia
and New Zealand Neonatal Network (ANZNN),
Canadian Neonatal Network (CNN), Israel Neonatal
Network (INN), Neonatal Research Network of Japan
(NRNJ), Swedish Neonatal Quality Register (SNQ),
Neonatal Network of Switzerland (SwissNeoNet),
Spanish Neonatal Network (SEN1500), and the United
Kingdom Neonatal Collaborative (UKNC).
The population-based sample included 24 503
singleton infants born between 240 and 286 weeks’
gestational age without a major congenital malforma-
tion. We included neonates <29 weeks’ gestation as
this is the highest risk cohort for adverse outcomes
related to preterm birth, and the population coverage
for admission to level 3 neonatal units was high
enough to avoid selection bias.
Gestational age was determined by the best esti-
mate based on early prenatal ultrasound, last men-
strual period, or physical examination at birth, in that
order. The following infants were excluded: 118
admitted after 36 weeks post-menstrual age, 19 for
missing data for sex, 1 for missing data for birth-
weight, 6 whose birthweight-for-gestational age was
© 2016 John Wiley & Sons Ltd
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>4 standard deviations away from the mean, and 571
who were missing data for the composite outcome.
The final sample size comprised 23 788 (97.1%)
infants.
Classiﬁcation of SGA
The birthweight of infants from each collaborator was
standardised relative to four different birthweight-
for-gestational age references (see below) and
expressed as a birthweight z-score.16,17 Infants with a
birthweight z-score <1.28 (equal to a birthweight
below the 10th percentile) were classified as SGA.
Birthweight-gestational age references
Descriptive (birthweight-based) references
For all iNeo collaborators, infants were classified as
SGA according to the common Fenton birthweight-
for-gestational age reference using the Lambda, Mu,
and Sigma (LMS) parameters for completed weeks’
gestational age provided by Dr. Fenton (personal
communication).
Each iNeo collaborator provided a published
descriptive birthweight-for-gestational age reference
for their population (Table 1).18–24 If the birthweight-
for-gestational age reference did not provide the mean
birthweight and standard deviation by sex and gesta-
tional age20,24 needed to calculate the birthweight
z-score, this information was obtained from the
network Director (INN, UKCC) from the data source
used in the publication. In contrast to the references
for other countries, the Japanese and Swedish national
birthweight-for-gestational age references excluded
infants born by caesarean delivery to reduce potential
bias in birthweight from including growth-restricted
infants in the reference charts.21,25,26 For Japan, we
combined the birthweight values for vaginal and cae-
sarean deliveries (obtained by the Director from the
same source as the published reference) to create a ref-
erence for this study. For Sweden, we used the Cana-
dian reference19 because the mean birthweight
adjusted for gestational age was similar in Canada
and Sweden (926 g and 925 g, respectively).
Estimated fetal weight (EFW)
For all iNeo collaborators, infants were classified as
SGA according to the common EFW reference
(Salomon14). This reference used ultrasound biometric
measures to derive EFW with the Hadlock equation27
to create fetal growth curves for males and females
born from 20 to 36 weeks’ gestational age. In addition,
we calculated country- and sex-specific EFW refer-
ences for each collaborator using the global fetal
weight reference proposed by Mikolajczyk et al.28 In
this method, the ratio of the mean birthweight of a
specific population at 40 weeks’ gestational age to that
of the original Hadlock sample27 is applied to calcu-
late EFW at each gestational age (assumes a constant
ratio across gestation). We used birthweight at
40 weeks’ gestational age from the country-specific
descriptive references and the default SD of 13.2 to
create an EFW reference for each collaborator.
Composite outcome
The primary outcome was a composite of mortality or
major morbidity. Because all morbidity outcomes
increase risk of mortality, such that a higher mortality
rate may result in lower morbidity rates among
survivors, we examined a composite outcome to
reduce such competing outcomes bias. The composite
outcome included mortality due to any cause prior to
discharge, major neurological injury defined as grade 3
or 4 intraventricular haemorrhage (IVH)29 or periven-
tricular echo densities/echo lucencies, treated
retinopathy of prematurity (ROP),30 or chronic lung
disease defined as oxygen requirement at 36 weeks’
post-menstrual age or at discharge.31 We also present
analyses with mortality alone as the outcome (Table S2).
Statistical analysis
The percentage of infants classified as SGA and corre-
sponding 95% confidence intervals (CI) were esti-
mated for the entire cohort and separately for each
collaborator according to each of the four birthweight-
for-gestational age references.
For each birthweight-for-gestational age reference,
the Mantel–Haenszel relative risk for SGA was calcu-
lated controlling for gestational age, sex, antenatal cor-
ticosteroids, and method of delivery. Adjusted RR was
calculated for the composite outcome and for mortality
separately using the entire cohort and separately for
each iNeo collaborator. The attributable fraction (the
proportion of the composite outcome in SGA infants
that can be attributed to SGA) was calculated using the
adjusted RR by the formula: (RR  1)/RR.
© 2016 John Wiley & Sons Ltd
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Adjusted RR estimates comparing the composite
outcome between each pair of collaborators adjusted
for SGA were also estimated for each birthweight-for-
gestational age reference. The impact of adjusting for
SGA derived from different birthweight-for-gestational
age references was evaluated by calculating the per-
centage difference between the pairwise adjusted RR
estimates. A difference of 10% or more in the pairwise
adjusted RR estimates was considered a meaningful
difference.
All statistical analyses were conducted using SAS
version 9.2 with statistical significance evaluated
using two-sided test at the 5% level.
Results
Within the total cohort, median gestational age was
26 weeks and varied from 26 to 27 weeks between
collaborators (Table 2). Mean birthweight varied sig-
nificantly across collaborators, ranging from 865 g for
NRNJ to 935 g for ANZNN. The proportion of
caesarean deliveries differed significantly between
collaborators ranging from 40% for UKNC to 77% for
SwissNeoNet. The proportion of antenatal corticos-
teroid use ranged from 47% for NRNJ to 89% for
ANZNN.
The percentage of infants classified as SGA in the
total cohort was 9.9% (95% CI 9.5, 10.2) for the com-
mon (Fenton) reference12 and 11.1% (95% CI 10.7,
11.5) for country-specific birthweight-based references
(Table 3). Compared with the birthweight references,
the EFW references classified a higher percentage
of infants as SGA [28.6% (95% CI 28.0, 29.2) for the
common EFW and 24.6% (95% CI 24.1, 25.2) for
country-specific EFW references]. All infants classified
as SGA by birthweight-based references were also
classified as SGA by EFW-based references.
For all birthweight-for-gestational age references,
the percentage of infants classified as SGA varied
significantly between collaborators (Pearson chi-square
P < 0.0001; Table 3). For the common birthweight ref-
erence (Fenton), SGA ranged from 7.8% in ANZNN to
15.3% in SwissNeoNet. Compared with the Fenton
reference, the percentage SGA computed using the
country-specific birthweight-based references was gen-
erally higher. For the common EFW reference, the per-
centage SGA ranged from 24.6% in ANZNN to 36.5%
in SwissNeoNet. The percentage of SGA was lower for
the country-specific EFW-based references compared
with the common EFW-based reference for INN, T
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NRNJ, and UKNC. We note that the percentage
SGA in the NRNJ was among the highest using all
birthweight-for-gestational age references, except for
the country-specific EFW reference, where it had the
lowest percentage (20.8%).
Compared with non-SGA infants, SGA infants iden-
tified by all birthweight-for-gestational age references
were born at a later gestational age, had a higher fre-
quency of caesarean delivery, and were more likely to
receive antenatal corticosteroids (Table S1).
In the total cohort, SGA infants had a significantly
higher adjusted RR of the composite outcome com-
pared with non-SGA infants for all birthweight-for-
gestational age references (Table 3). The adjusted RRs
comparing the composite outcome for SGA to non-
SGA infants were similar when SGAwas derived from
the common or country-specific references. However,
the adjusted RRs tended to be lower when SGA was
derived from EFW references compared with birth-
weight references. The adjusted RRs for SGA were
fairly similar across collaborators within each reference
with slightly higher RR reported for the SwissNeoNet.
Based on the adjusted RR, the fraction of the com-
posite outcome in SGA infants that could be attributed
to SGA was 32% for both common and country-
specific birthweight references, 26% for common EFW
reference, and 28% for country-specific EFW reference.
The association of SGA with mortality tended to be
stronger than with the composite outcome, with
adjusted RRs for the whole cohort ranging from 1.66
(95% CI 1.55, 1.77) for the common EFW reference to
2.11 (95% CI 1.95, 2.27) for the country-specific
birthweight-based references (Table S2).
Sensitivity analyses examined more stringent
cut-offs to classify SGA for the common EFW reference.
For a cut-off of 2 SD, the percentage of SGA was
16.4% (95% CI 15.9, 16.8) and the adjusted RR for SGA
for the composite outcome was 1.45 (95% CI 1.41, 1.50).
A birthweight z-score of < 2.60 identified 10% of
infants as SGA and resulted in an adjusted RR of 1.52
(95% CI 1.48, 1.58). These adjusted RR are similar to
those obtained using the BW-based references.
The composite outcome varied significantly between
collaborators (overall P < 0.0001; data not shown). The
percent differences in the adjusted RR estimates of the
composite outcome for pairwise comparisons between
collaborators adjusted for SGA derived from different
birthweight-for-gestational age references were all <4%
and were below the 10% level determined a priori as a
meaningful difference.
Comment
In this large international cohort of preterm infants
born between 24 and 28 weeks’ gestational age, the
percentage of infants classified as SGA was 10% and
11% using common and country-specific birthweight-
based references, respectively, compared with 29%
and 25% when sonographic EFW-based references
were used. For each birthweight-for-gestational age
reference and for all countries, infants classified as
SGA had higher risk for the composite outcome com-
pared with non-SGA infants. Overall and within each
country, the magnitude of the adjusted RRs for the
composite outcome was similar when SGA status was
determined using the common or country-specific
birthweight-based references. However, the adjusted
RR estimates tended to be lower when SGA was deter-
mined from EFW-based references compared with
birthweight-based references.
Country-speciﬁc vs. common birthweight-for-
gestational age references
The effect of using a common or country/ethnic-
specific birthweight-for-gestational age reference in
multi-country/ethnic populations has been exam-
ined using both birthweight and EFW-based refer-
ences, but studies were generally limited to
stillbirths or mortality outcomes and did not focus
specifically on very preterm infants.5,10,28,32,33 Com-
mon references, generally based on predominantly
Caucasian populations in high-income countries,
resulted in a higher percentage of SGA infants and
a lower OR for the association of SGA with
adverse neonatal outcomes compared with country/
ethnic-specific references.5,10,28,32,33 This effect is
particularly evident for East and South Asian infants,
who have a substantially lower average birthweight
relative to Caucasian populations.5,32,33
In our study, the common (Fenton) birthweight-
based reference classified a slightly lower percentage
of infants as SGA compared with the country-specific
birthweight references in the combined cohort. The
Fenton reference was developed with birthweight
data from North American and Western European
countries, and the similarity of results using Fenton
and country-specific descriptive references is not
surprising. As expected, countries with the lowest mean
birthweight (Japan and Switzerland) had the highest
percentage SGA with the common Fenton reference.
© 2016 John Wiley & Sons Ltd
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There was minor difference in the percentage of
SGA for the common EFW-based reference and the
country-specific EFW-based references, with a slight
increase in the adjusted RR in SGA neonates for the
composite outcome and for mortality. Even though
references for country-specific estimation of SGA
were derived from each country, a small degree of dif-
ference was expected due to some differences in the
population due to immigration, when the reference
was created because slow and steady change in birth-
weight has been observed over the years and mar-
ginal error due to sampling differences. This may lead
to both exaggeration and dilution of differences
between country-specific references and common ref-
erences. More extreme differences have been reported
by Mikolajczyk et al.,28 where SGA decreased from
35% using the common EFW reference to 11% for
country-specific EFW references, and the odds ratio
for SGA compared with non-SGA for perinatal mor-
tality increased substantially. The larger effect of
country-specific references in that study likely reflects
the fact that average term birthweight in the 24 Afri-
can, Latin American, and Asian countries was much
lower than that of the reference population.
EFW-based compared with birthweight-based
birthweight-for-gestational age references
The risk of developing the composite outcome for
infants identified as SGA using the EFW-based refer-
ences was lower than that for those identified using
birthweight-based references. In agreement with this
result, a lower OR for SGA was also reported for
neonatal mortality in preterm infants when an
EFW-based reference was compared with birthweight-
based references.34,35 The lower risk associated with
SGA reflects the fact that the higher birthweight cut-
offs of the EFW reference classify a higher number of
infants as SGA who represent a less extreme risk
group compared with infants classified as appropriate
for gestational age. We note that applying a lower cut-
off (birthweight z-score <2.60) for the common EFW
reference to classify 10% of infants as SGA resulted in
similar adjusted RR estimates as the Fenton reference.
SGA adds little to prediction of individual outcomes
SGA infants were at significantly higher risk for the
composite outcome and mortality compared with
non-SGA infants irrespective of the reference used to
classify SGA. Thus, it is an important clinical message
that preterm SGA infants need special attention for
their care and management. However, SGA status has
limited predictive ability for adverse outcomes on an
individual level,28,32,36 and newer methods, such as
determining a sliding scale based on impact on out-
comes, or additional markers, such as head circumfer-
ence or indicators of symmetry of growth,37 are
needed to better differentiate healthy small babies
from pathologically growth-restricted babies.
The choice of birthweight-for-gestational age refer-
ence does have implications for neonatologists and
perinatologists. EFW-based references (using the
10th percentile cut-off) identify a substantially
greater number of SGA infants compared with birth-
weight-based references; however, the population of
infants identified may be at lower risk of adverse out-
comes. The use of EFW-based references may thereby
increase stress to parents and increase health care
costs (as a result of monitoring/intervention more
neonates), with marginal benefit, if any, with regards
to impact on outcomes. However, this is not to
undermine the importance of identifying fetal
growth restriction as such infants need to be followed
closely.
One striking finding was the similarity of adjusted
RR for SGA for adverse outcomes amongst all collabo-
rators of iNeo. This may indicate that the impact of
SGA we observed could be used to calculate attributa-
ble risk estimates and the fact that we only included
extremely low gestation neonates from high-resource
countries could support biological plausibility of
impact of SGA on mortality and morbidities.
Strengths and limitations
The large sample size of very preterm infants, the
international nature of our cohort derived from eight
national data collection systems in nine countries, and
our ability to examine a composite adverse outcome
(rather than mortality alone) are major strengths of
our study. In addition, the accuracy of gestational age
and birthweight data is likely high because we exam-
ined high-resource countries where a large proportion
of women had early ultrasound to determine
gestational age. However, the focus on high-resource
countries may reduce generalisability of our results.
In other contexts, the use of different birthweight for
GA references may have greater influence on the risks
associated with SGA and/or cross country compar-
© 2016 John Wiley & Sons Ltd
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isons of neonatal outcomes. In addition, our study
was limited to short-term neonatal outcomes, and the
comparison of different birthweight-for-gestational
age references may yield different results when exam-
ining long-term developmental outcomes.38 Although
we attempted to harmonise outcome definitions
between contributors by generalising classifications,
inconsistency in definitions of individual morbidities
may have contributed to international variations in
the composite outcome. However, the association of
SGA with the outcome was similar between contribu-
tors, and variation in the definitions does not likely
affect our comparison of different birthweight-for-
gestational age references.
Conclusions
International (common) growth standards are widely
used for children39 and have recently been published
for infants born >32 weeks’ gestational age.40 In
our study of preterm infants of 24–28 weeks’ gesta-
tional age, the use of common or country-specific
birthweight-based references had little influence on
the percentage of infants classified as SGA or the asso-
ciation of SGA with neonatal outcome. For studies of
neonatal outcomes in preterm infants where SGA clas-
sification is important to compare baseline character-
istics and/or for use as a confounding variable, we
propose to use the Fenton birthweight-based reference
for high-resource countries. This reference was
created from data from a large number of preterm
infants from several countries and removes potential
variation associated with independently derived
country-specific birthweight-based references. Ongoing
work by others examining fetal growth using ultra-
sound across different populations will provide more
information on whether international or country-
specific standards are appropriate for very preterm
infants.11,41
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